Roberto Mina

15PUBLICATIONS
73CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsImmunogenetics (incl. genetic immunology)Medical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 06, 2026
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.

Francesca Gay, Wilfried Roeloffzen, Meletios A Dimopoulos

|Jul 17, 2025
Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma.

Ola Landgren, Noa Biran, Elizabeth K O'Donnell

|Jul 03, 2025
Are we ready for an MRD-driven approach in multiple myeloma?

Francesca Gay, Roberto Mina

|Feb 13, 2025
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts.

Mattia D'Agostino, Marina Martello, Lorenzo De Paoli

|Dec 05, 2024
It's in your (peripheral) blood.

Roberto Mina, Mattia D'Agostino

|Oct 04, 2024
Impact of daratumumab on collection and engraftment in multiple myeloma patients undergoing hematopoietic stem cell mobilization with G-CSF plus on-demand plerixafor.

Giuseppe Bertuglia, Bruno Garibaldi, Andrea Casson

Pageof 3

Frequent Collaborators

4 joint publications

Francesca M Gay

3 joint publications

Paolo Corradini

2 joint publications

Mattia D'Agostino

2 joint publications

Katja C Weisel